Its probably not the way GlaxoSmithKline (GSK) had hoped to start the second half of the year. The U.S. unit of GSK today agreed to plead guilty and pay a criminal fine of $956.8 million for marketing drugs for unapproved uses.
By Alex VorroJuly 02, 2012
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.